When you visit Andrew Steckl's lab at the University of Cincinnati, you see a nondescript glass box that weaves together different fibers.
Materials Science
Oct 25, 2019
0
392
Worldwide, approximately one in four people is infected by Mycobacterium tuberculosis and while overall New Zealand has relatively low rates of TB, Māori and Pacific people are eight times more likely to be affected than ...
Cell & Microbiology
Oct 15, 2019
0
9
Researchers at the University of Copenhagen have used highly sophisticated molecular analyses to identify key proteins in the signaling pathways that cancers use to spread in the body. The study could help in personalizing ...
Cell & Microbiology
Oct 4, 2019
0
45
One of the WHO's three critical priority pathogens, Acinetobacter baumannii, for which new antibiotics are urgently needed is one step closer to being tackled, as researchers from the Department of Chemistry—University ...
Biochemistry
Sep 24, 2019
0
64
Drug-resistant bacteria responsible for deadly hospital-acquired infections shut out antibiotics by closing tiny doors in their cell walls.
Cell & Microbiology
Sep 2, 2019
0
427
Tissue engineers create artificial organs and tissues that can be used to develop and test new drugs, repair damaged tissue and even replace entire organs in the human body. However, current fabrication methods limit their ...
Materials Science
Aug 23, 2019
0
652
Researchers reveal previously undiscovered hot spots on the surface of bacteria's critical enzyme, which could guide novel approaches to antibiotic design.
Cell & Microbiology
Aug 1, 2019
0
8
Researchers at the Indian Institute of Science (IISc) have designed an antimicrobial peptide (AMP) that can effectively and quickly kill a notorious multidrug-resistant bacterium called Acinetobacter baumannii.
Biochemistry
Jul 30, 2019
0
163
Unregulated cell division is a hallmark of cancer, and one of the key proteins involved in controlling cell division is called FoxM1. Abnormal activation of FoxM1 is a common feature of cancer cells and is correlated with ...
Cell & Microbiology
May 28, 2019
0
49
A growing number of infections—such as pneumonia, gonorrhea and tuberculosis—are becoming harder to treat, as bacteria evolve defenses against antibiotics faster than we can develop new drugs to replace them.
Cell & Microbiology
May 16, 2019
0
54
